Jim Cramer Blog

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
On Semiconductor (NasdaqGS:ONNN - News). ONNN's PowerRating (for Traders) is 6.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
ImClone Systems (NasdaqGS:IMCL - News). IMCL's PowerRating (for Traders) is 6.
Bearish
Laps Up 5% or More: These are stocks that lap up by 5% or more and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that lap up by more than 5% have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Medicines Company (NasdaqGS:MDCO - News). MDCO's PowerRating (for Traders) is 3.
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Sara Lee (NYSE:SLE - News). SLE's PowerRating (for Traders) is 4.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Autozone (NYSE:AZO - News). AZO's PowerRating (for Traders) is 3.
2-Period RSI Above 98: These are stocks that have a 2-day RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
American International Group (NYSE:AIG - News). AIG's PowerRating (for Traders) is 4.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Moody's (NYSE:MCO - News). MCO's PowerRating (for Traders) is 3.
Published By TradingMarkets.com

Labels: AIG, AZO, Hot Stocks, IMCL, MCO, MDCO, ONNN, SLE

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.

ImClone Systems (NasdaqGS:IMCL - News). IMCL's PowerRating (for Traders) is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Verigy (NasdaqGS:VRGY - News). VRGY's PowerRating (for Traders) is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
InterOil (NYSE:IOC - News). IOC's PowerRating (for Traders) is 8.
Bearish
Laps Up 5% or More: These are stocks that lap up by 5% or more and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that lap up by more than 5% have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Kellwood (NYSE:KWD - News). KWD's PowerRating (for Traders) is 3.
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Marvel Entertainment (NYSE:MVL - News). MVL's PowerRating (for Traders) is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Starwood Hotels & Resorts (NYSE:HOT - News). HOT's PowerRating (for Traders) is 3.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Bear Stearns (NYSE:BSC - News). BSC's PowerRating (for Traders) is 3.

Published By TradingMarkets.com

Labels: BSC, HOT, Hot Stocks, IMCL, IOC, KWD, MVL, VRGY

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
ImClone Systems (NasdaqGS:IMCL - News). IMCL's PowerRating (for Traders) is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Verigy (NasdaqGS:VRGY - News). VRGY's PowerRating (for Traders) is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
InterOil (NYSE:IOC - News). IOC's PowerRating (for Traders) is 8.
Bearish
Laps Up 5% or More: These are stocks that lap up by 5% or more and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that lap up by more than 5% have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Kellwood (NYSE:KWD - News). KWD's PowerRating (for Traders) is 3.
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Marvel Entertainment (NYSE:MVL - News). MVL's PowerRating (for Traders) is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Starwood Hotels & Resorts (NYSE:HOT - News). HOT's PowerRating (for Traders) is 3.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Bear Stearns (NYSE:BSC - News). BSC's PowerRating (for Traders) is 3.
Published By TradingMarkets.com

Labels: BSC, HOT, Hot Stocks, IMCL, Imclone Systems Inc., IOC, KWD, Marvell Technology Group Ltd., MVL, Verigy Ltd., VRGY

Shares of ImClone Systems Inc. dropped Friday after a Friedman Billings Ramsey analyst downgraded the stock and reversed a recent price target increase, saying experts told him they will probably not use the company's Erbitux to treat most cases of lung cancer.

ImClone shares rocketed 18.4 percent Tuesday after the biotechnology company, along with Bristol-Myers Squibb Co., said a late-stage study showed Erbitux improved survival in non-small cell lung cancer.
ImClone and Bristol-Myers plan to release data from the trial at a future medical conference.
Analyst Jim Reddoch slashed his price target to $45 per share from $64, and lowered his rating to "Market Perform" from "Outperform." After Tuesday's news, Reddoch raised his price target from $50.

Labels: IMCL, Imclone Systems Inc.

Here are 7 options to watch for Today.
Most Underpriced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
CME Group Oct 610 Calls (NYSE:CME - News). CME's PowerRating (for Traders) is 6.
Most Underpriced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
Google Sep 520 Puts (NasdaqGS:GOOG - News). GOOG's PowerRating (for Traders) is 6.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
Accredited Home Lenders Oct 10 Calls (NasdaqGS:LEND - News). LEND's PowerRating (for Traders) is 3.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Intuitive Surgical Oct 185 Puts (NasdaqGS:ISRG - News). ISRG's PowerRating (for Traders) is 7.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
ImClone Systems (NasdaqGS:IMCL - News). IMCL's PowerRating (for Traders) is 2.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock.
KeyCorp (NYSE:KEY - News). KEY's PowerRating (for Traders) is 4.
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
Toll Brothers (NYSE:TOL - News). TOL's PowerRating (for Traders) is 6.
By TradingMarkets Research

Labels: Accredited Home Lenders Holding Co., CME, GOOG, IMCL, ISRG, KEY, LEND, stock options, TOL

ImClone Systems Inc. and Bristol-Myers Squibb Co. claimed Tuesday that the drug Erbitux improved the survival rate of patients with the most common type of lung cancer in a late-stage study. ImClone shares jumped 18 percent.
The drug, already approved to treat colon cancer and head and neck cancer, was given to patients with advanced, non-small cell lung cancer in combination with chemotherapy treatment. The study compared the combination to chemotherapy alone.
ImClone officials could not be reached for comment on the results. It is unclear whether the study data has been fully reviewed by the company or an independent monitor.

Labels: BMY, Bristol-Meyers Squibb, IMCL, Imclone Systems Inc.

Stocks staged a broad-based rally as investors speculated that consumer demand will help aid the economy. At the close, all major market averages ended the day with strong gains. The price of Gold continued to rise, ending up $8.90 to $721.10 an ounce.
OPEC said it would increase oil production by 500,000 barrels of oil a day as they believe near record oil prices would damage the world economy. The increase in output will mostly be led by Saudi Arabia. This is the first production increase by OPEC in more than a year. Oil prices were nevertheless up 74 cents to $78.23 a barrel.
Shares of McDonald's (NYSE: MCD - News) rose 3.2% after the burger giant reported an 8.1% same-store sales increase for the month of August. In the U.S., the world's largest restaurant chain said same-store sales grew 7.4% fueled by breakfast and new food and beverage offerings. Its European business also experienced a 6.1% rise in store sales growth buoyed by summertime offerings. In its Asia/Pacific, Middle East and Africa region, the company said sales surged 12.4% helped by extended hours and new menu promotions. The company noted that sales were particularly robust in China, Japan and Australia. Subscribers can read our analysis of McDonald's in today's issue.
Biotech firm Imclone Systems (Nasdaq: IMCL - News) pleased investors today after a study released by Germany's Merck KGaA said that Imclone's Erbitux prolonged the survival of lung cancer patients. The drug is used to treat colon cancer, in addition to head-and-neck cancer. Shares surged 18%. Sepracor (Nasdaq: SEPR - News) and GlaxoSmithKiline (NYSE: GSK - News) agreed to team up on Sepracor's insomnia drug Lunesta. Under the terms of the agreement, Glaxo will commercialize the drug in markets outside the U.S., while Sepracor stands to receive an initial payment of $20 million, plus subsequent milestone payments that could total up to $155 million. Additionally, Sepracor will receive double-digit royalties that will increase in line with sales and compensation. The drug is currently under review by the European Union, where a decision is expected in the second half of 2008.
In tech news, VMware (NYSE: VMW - News) struck a deal to acquire Swiss based Dunes Technologies, a maker of virtualization management software. Financial terms of the deal were not disclosed. Storage maker Western Digital (NYSE: WDC - News) upped its first quarter sales and profit forecast based on strong demand for hard disk drives. For the current quarter, the company now sees EPS reaching 61-65 cents, excluding charges related to its recent acquisition of Komag. Its previous forecast was for EPS of 43-47 cents a share. The company also noted that gross margins are expected to improve to 17.5%. Shares advanced 4.4% on the news.
In earnings news, video game maker Take-Two Interactive (Nasdaq: TTWO - News) reported a narrower-than-expected loss for its third quarter. The company lost -$58.5 million, or -81 cents a share, compared to a loss of -$91.4 million, or -$1.29 a share in the same period a year ago. Excluding items, loss was -$46.1 million, or -64 cents a share versus the loss of -67 cents per share expected by analysts. Sales fell to $241.2 million, but beat estimates for revenue of $200.6 million. For the fourth quarter Take-Two expects a loss of -20 to -25 cents a share on revenue of $275-300 million.
By The BullMarket.com Staff

Labels: GSK, IMCL, MCD, SEPR, TTWO, VMW, WDC

Here are 7 stocks for traders for Wednesday:
Brady (NYSE:BRC - News) should report $0.57 EPS before the bell on Wednesday morning. BRC's PowerRating (for Traders) is 6.
When Gerber Scientific (NYSE:GRB - News) announces earnings on Wednesday before the bell, watch for $0.08 EPS. GRB does not have a PowerRating (for Traders) due to volume restraints.
Jos. A. Bank (NasdaqGS:JOSB - News) reports earnings on Wednesday morning; look for $0.42 EPS. JOSB's PowerRating (for Traders) is 5.
General Motors (NYSE:GM - News) rose over 3% on Tuesday after the company said it needed fewer incentives to attract buying customers. GM's PowerRating (for Traders) is 5.
McDonald's (NYSE:MCD - News) rose as much as 4% on Tuesday after reporting that same-store sales increased over 8% worldwide from last August. MCD's PowerRating (for Traders) is 5.
ImClone (NasdaqGS:IMCL - News) rose over 20% on Tuesday after announcing positive trial results for the company's new lung cancer drug. IMCL's PowerRating (for Traders) is 2.
Countrywide Financial (NYSE:CFC - News) announced on Tuesday it was brokering its second multi-billion bailout in the last month. CFC's PowerRating (for Traders) is 7.
PowerRatings (for Traders) are courtesy of TradingMarkets.com

Labels: BRC, CFC, GM, GRB, Hot Stocks, IMCL, JOSB, MCD

Shares of German drugmaker Merck KGaA climbed sharply Tuesday after the company released successful new study results for its cancer drug Erbitux. Shares of biotechnology company ImClone, which developed the drug, soared nearly 24 percent in the U.S.
Merck shares rose more than 5.7 percent at 97.56 euros ($134.52) in Frankfurt trading. ImClone Systems Inc., from which Merck bought the Erbitux licensing rights for outside the U.S. and Canada from in 1998, jumped 21 percent to $45.93, up $8.
Merck said the phase III study, carried out on patients with advanced non-small cell lung cancer, showed that when Erbitux was combined with chemotherapy, it led to increased overall survival rates compared with when chemotherapy was used alone.
Erbitux is already among Darmstadt-based Merck's top-selling products, and the study results appeared to strengthen its prospects.
"Non-small cell lung cancer that has spread from the primary site is extremely difficult to treat so we are delighted with these results," said Wolfgang Wein, the company's senior executive vice president for oncology.
Published by AP

Labels: Cancer Drugs, IMCL, MRK

Here are 7 options to watch for today. This list comes directly from the TradingMarkets Options Indicators page. The list is created using OptionVue options analysis software.
Most Underpriced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.

iShares MSCI Emerging Markets Index July 140 Calls (AMEX:EEM). EEM's PowerRating is 5.
Most Underpriced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
Valero Energy Corp. July 72.5 Puts (NYSE:VLO). VLO's PowerRating is 5.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
InterContinental Exchange Inc. July 180 Calls (NYSE:ICE). ICE's PowerRating is 3
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Foster Wheeler Aug 90 Puts (NasdaqGS:FWLT). FWLT's PowerRating is 3.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
Blue Nile Inc. (NasdaqGS:NILE). NILE's PowerRating is 4.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock.
None today
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
Time Warner Inc. (NYSE:TWX). TWX's PowerRating is 5.
Imclone Systems Inc. (NasdaqGS:IMCL). IMCL's PowerRating is 6.
PowerRatings are courtesy of TradingMarkets.com

Labels: EEM, FWLT, ICE, IMCL, NILE, stock options, TWX, VLO

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
CBOT Holdings (NYSE:BOT) & Snap-On (NYSE:SNA). BOT's PowerRating is 6, and SNA's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Nicor (NYSE:GAS). GAS's PowerRating is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
ImClone Systems (NasdaqGS:IMCL) & Macerich (NYSE:MAC). IMCL's PowerRating is 9, and MAC's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Scripps Company (NYSE:SSP). SSP's PowerRating is 4.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Kraft Foods (NYSE:KFT). KFT's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: BOT, GAS, Hot Stocks, IMCL, KFT, Mac, SNA, SSP

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.

Ryerson (NYSE:RYI) & St. Joe Company (NYSE:JOE). RYI's PowerRating is 7, and JOE's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Nicor (NYSE:GAS). GAS's PowerRating is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Hasbro (NYSE:HAS) & ImClone (NasdaqGS:IMCL). HAS's PowerRating is 7, and IMCL's PowerRating is 8.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
McClatchy (NYSE:MNI). MNI's PowerRating is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Canetic Resources Trust (NYSE:CNE). CNE's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: CNE, GAS, HAS, Hot Stocks, IMCL, JOE, MNI, RYI

Stocks traded aimlessly again today as investors waited for the start of earnings season, which traditionally kicks off with an announcement from aluminum producer Alcoa (NYSE: AA - News). The major market averages all managed to post modest gains. Oil prices were also higher, as was the 10-year Treasury note, which saw its yield drop to 4.72%.
Housing was once again in the spotlight as homebuilder D.R Horton (NYSE: DHI - News) announced that is Q2 sales orders fell 37% overall, paced by even steeper declines in the formerly booming California and the Southwest markets. The company's net orders totaled 9,983 homes, down from 15,771 homes last year. Horton's Q2 ended March 31st. The stock closed -1.5% lower.
In corporate news, Swedish telecom equipment maker LM Ericsson (Nasdaq: ERIC - News) signed a deal to manage a portion of the European network of Vodafone (NYSE: VOD - News). Ericsson's shares added 3.6% on the news. Citigroup (NYSE: C - News) was up 1.6% as investors waited for the results of its long-anticipated cost review. Generic drugmaker Mylan Laboratories (NYSE: MYL - News) rose 2.8% after it raised its 2007 profit forecast to a range of $1.60 to $1.63 a share, up from its previous guidance of $1.50 to $1.55 per share. Mylan cited strength in its generics business, including new product launches, for its upbeat forecast.
The flip side of the drug business was exemplified by biopharmaceutical company Adolor (Nasdaq: ADLR - News), which saw its shares plunge -58.7% after it announced that it stopped a study of a new drug to treat opioid-induced (OIC) constipation over safety concerns. The drug, Entereg, was being developed in association with British drugmaker GlaxoSmithKline (NYSE: GSK - News). Several analysts swiftly issued downgrades for Adolor, while Brean Murray Carret reiterated its "sell" recommendation. Progenics Pharmaceuticals (Nasdaq: PGNX - News), which submitted its own OIC compound for FDA approval last Friday along with partner Wyeth (NYSE: WYE - News), added 1.5% today.
Shares of ImClone Systems (Nasdaq: IMCL - News) also slid -6.4% on poor trial results. The company said a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer. Erbitux is already approved for treatment of colorectal cancer, and head and neck cancer.
In M&A news, Biosite (Nasdaq: BSTE - News) said it will enter merger talks with Inverness Medical Innovations (NYSE: IMA - News), which last week offered $90 a share for the maker of medical diagnostic tests. IMA's bid topped an earlier offer from Beckman Coulter (NYSE: BEC - News) of $85. All three companies are in the business of making medical test products.

Labels: AA, ADLR, BEC, BSTE, C, DHI, ERIC, GSK, IMA, IMCL, MYL, PGNX, VOD, WYE

ImClone Systems Inc. (NasdaqGS:IMCL - News) said on Tuesday that a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer, sending its shares down more than 7.5 percent.

Erbitux, which is already approved to treat colorectal cancer and head and neck cancer, and generated worldwide sales of $1.1 billion in 2006, is ImClone's sole product and the company had hoped to win approval for it to treat a new type of cancer.
But pancreatic cancer is notoriously difficult to treat and while investors had hoped for positive data, they had not banked on it.

Labels: IMCL, Imclone Systems Inc.

Stocks trade mixed Friday, but close the week with solid gains. The Dow (^DJI) added 19.87 points to close at 12,481.01. The S&P 500 (^SPX) gained 1.57 points to 1,436.11. The Nasdaq (^IXIC) lost 2।81 points to 2,448.93. Volume was light on the session with the NYSE trading 1.40 billion shares and the Naz turning over 1.67 billion. Market breadth was positive by an 18-to-14 and 16-to-14 margin on the Big Board and Naz respectively.
Economic news was a positive Friday with existing home sales rising 3.9 percent. This was much better than the decline economists were expecting and is the third straight month of gains. Existing home sales continue to benefit from low mortgage rates. However, with the subprime market seeing problems, future sales could be hurt by a shortage of lending options. At the same time, NY Fed President Geithner stated that he does not see evidence of the subprime problem spilling over to the broader credit market.
Shares of Amgen (AMGN) dropped 4.1 percent after the drug maker discontinued a clinical trial for its drug Vectibix. The company was hoping to get the drug approved for a chemotherapy program for colorectal cancer. Shares of ImClone (IMCL) gained 13.6 percent because the company makes Erbitux, a competing drug.
Shares of General Motors (GM) rose 5.5 percent on rumors that other companies were interested in bidding for DaimlerChrysler's (DCX) Chrysler division. It seems GM shareholders do not like the idea of buying Chrysler. Shares of DCX also gained ground, up 6.1 percent.
Shares of Nike (NKE) gained 0.4 percent on news profits rose almost 8 percent in the most recent quarter. The company stated that strength in Europe and Asia led to the these gains, but the shoe maker also stated that margins will be flat to lower in the current quarter throughout the year.
Oil prices rose for the second straight session on news 15 members of the British Navy were being held by Iranian forces. This pushed crude higher by 59-cents to $62.28 a barrel. For the week, oil prices were up 4.5 percent. The feeling is that economic growth might not decline as much as initially expected and this could lead to stronger energy demand.
Overall, the bulls have to be pleased with the strength seen this past week. Now focus will turn to a number key economic reports next week and to upcoming earnings announcements in the weeks to come.
Jody Osborne

Labels: AMGN, DCX, GM, IMCL, NKE

Here are 7 stocks for traders for Monday from TradingMarkets.com:
Dollar General (NYSE:DG - News) reports earnings Monday before the bell; watch for $0।38 EPS. DG's PowerRating is 3.
Tiffany & Co. (NYSE:TIF - News) is looking to report $1.05 EPS Monday before the market opens. TIF's PowerRating is 4.
Phillips-Van Heusen (NYSE:PVH - News) reports earnings after the close Monday, so watch for heightened price action and volume ahead of the bell. PVH's PowerRating is 5.
Amgen (NasdaqGS:AMGN - News) announced negative results for a new trial cancer drug on Friday, which boosted competitor ImClone (NasdaqGS:IMCL - News). AMGN's PowerRating is 5, and IMCL's PowerRating is 3.
Kraft Foods (NYSE:KFT - News) announced that it will be joining the S&P 500 on March 30 of this year. KFT's PowerRating is 3.
It was reported that Citigroup (NYSE:C - News) is eying the Dutch bank ABN Amro as an acquisition target. C's PowerRating is 5.
PowerRatings are courtesy of PowerRatings.net

Labels: AMGN, C, DG, Hot Stocks, IMCL, KFT, PVH, TIF

For the second day in a row, stocks hovered close to unchanged without any major catalysts emerging to inspire buyers or sellers. All three major indexes managed to close in positive territory bolstered by better-than-expected housing data as well as reports of potential M&A activity in the auto sector.
The National Association of Realtors announced that existing home sales jumped by the biggest amount in almost three years, jumping 3.9% in February to an annual rate of 6.69 million. Analysts had expected a drop in existing home sales. At the same time, however, the median home price dropped year over year for the seventh month in a row and the inventory of unsold homes rose. Earlier this week, the Fed noted that there is an ongoing "adjustment" occurring in the housing market.
In corporate news, DaimlerChrysler (NYSE: DCX - News) spiked 6% higher amid growing speculation that the company will sell off its Chrysler arm. Larger private equity firms like Cerberus Capital Management and Blackstone Group have reportedly been in contact with Chrysler management regarding a deal. The news contributed to a 6% gain in shares of fellow beleaguered automaker General Motors (NYSE: GM - News), which also announced grants of performance-based restricted stock units to executives.
In other M&A news, office-supply firm Avery Dennison (NYSE: AVY - News) announced that it will buy Paxar (NYSE: PXR - News), a maker of clothing labels and tags, for more than $1.3 billion. The offer of $30.50 per share represents a 27% premium based on Paxar's closing price on Thursday. Staffing services firm Kronos (Nasdaq: KRON - News) spiked 14% after announcing that it will be acquired by private equity firm Hellman and Friedman for around $1.8 billion.
Footwear and athletic apparel giant Nike (NYSE: NKE - News) reported earnings after the bell yesterday. The company handily beat FQ3 EPS estimates and posted sales just above the consensus. However, the company indicated that gross margins may come under pressure in the current quarter. The stock opened lower but managed to recoup most of those losses during the day. Smaller rival Under Armour (NYSE: UA - News) was up 2% on the day helped by positive comments from Jim Cramer.
Both Amgen (Nasdaq: AMGN - News) and Genentech (NYSE: DNA - News) dropped lower today. Amgen was hit after halting a study for colorectal cancer drug Vectibix. ImClone Systems (Nasdaq: IMCL - News), which co-markets competing drug Erbitux with Bristol-Myers Squibb (NYSE: BMY - News), spiked 14% on the news. Genentech dropped after announcing that its Q1 sales will be flat sequentially.

Labels: AMGN, AVY, BMY, DCX, DNA, GM, IMCL, KRON, NKE, PXR, UA

Symbol
Name
Last Trade
Change
Volume
Related Info
JDO
JED OIL INC
2.2199 2:46PM ET
0.6299 (39.62%)
1,135,200
Chart, Profile, More
BELFA
BEL FUSE CL A
37.00 2:47PM ET
7.87 (27.02%)
420,342
Chart, , More
EGR
COMMERCE ENERGY GP
2.45 2:45PM ET
0.40 (19.51%)
414,000
Chart, Profile, More
PXR
PAXAR CP
28.53 2:45PM ET
4.50 (18.73%)
5,188,400
Chart, Profile, More
ASTIW
ASCENT SOLAR TECH
3.38 2:49PM ET
0.54 (19.01%)
770,249
Chart, , More
BSML
BSML INC
1.40 1:53PM ET
0.19 (15.70%)
2,700
Chart, Profile, More
BELFB
BEL FUSE INC CL B
37.93 2:50PM ET
4.69 (14.11%)
313,081
Chart, Profile, More
SMXC
SMITHWAY MOTOR XPR
10.31 2:50PM ET
1.31 (14.56%)
273,917
Chart, Profile, More
KRON
KRONOS INC
53.00 2:51PM ET
6.37 (13.66%)
6,350,062
Chart, Profile, More
IMCL
IMCLONE SYSTEMS
38.34 2:51PM ET
4.46 (13.16%)
21,965,923